In this episode, we will be discussing one of the major breakthroughs of the decade in the field of healthcare technology: Real-World Evidence and Real-World Data. Our guest will share his thoughts and first-hand insights on how big data is going to transform the pharmaceutical research within the next 5 to 10 years. Please meet, Alex Loleit, Chief Strategy and Product Officer at DM RWE.
0:42 What is RWE and RWE?
1:16 Main sources for Real World Data
1:53 Does RWE complement clinical trial designs or has a real potential of replacing conventional research?
2:16 Issues and limitations when it comes to Real-World Evidence
2:37 Regulatory framework for RWE in Russia
Enjoy and subscribe to our YouTube channel to be the first to know about new content on clinical research.
Webpage: [ Ссылка ].
Experience: [ Ссылка ].
Blog, articles, case studies: [ Ссылка ].
LinkedIn: [ Ссылка ]
✉Reach out to become the next speaker: pr@oct-clinicaltrials.com
✉Submit an RFP for clinical services: info@oct-clinicaltrials.com
#cro #octclinical
DM RWE is a tech startup offering a wide range of Real-World Evidence (RWE) solutions with access to millions of electronic health records. With over 200 projects under its belt the company also delivers clinical data management and biostatistics services and a software for clinical research to pharma, biotech companies, and CROs. Learn more: [ Ссылка ]
#rwe #realworlddata #clinicalresearch
